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Summary 
A trinucleotide repeat (CAG) expansion in the hunting- 
tin gene causes Huntington's disease (HD). In brain 
tissue from HD heterozygotea with adult onset and 
more clinically severe juvenile onset, where the largest 
expansions occur, a mutant protein of equivalent in- 
tensity to wild-type huntingtin was detected in cortical 
synaptosomes, indicating that a mutant species is syn- 
thesized and transported with the normal protein to 
nerve endings. The increased size of mutant hunting- 
tin relative to the wild type was highly correlated with 
CAG repeat expansion, thereby linking an altered elec- 
trophoretic mobility of the mutant protein to its abnor- 
mal function. Mutant huntingtin appeared in gray and 
white matter with no difference in expression in af- 
fected regions. The mutant protein was broader than 
the wild type and in 6 of 11 juvenile cases resolved as 
a complex of bands, consistent with evidence at the 
DNA level for somatic mosaicism. Thus, HD pathogen- 
esis results from a gain of function by an aberrant pro- 
tein that is widely expressed in brain and is harmful 
only to some neurons. 
Introduction 
Huntington's disease (HD) is an autosomal dominant disor- 
der that causes progressive impairment of cognitive and 
motor functions, significant forebrain atrophy, and severe 
loss of neurons, particularly in the striatum. The disease 
leads to incapacitation and premature death (Dunlap, 
1927; Vonsattel et al., 1985; Folstein, 1989; Young, 1994). 
Patients with adult onset HD manifest clinical signs by the 
age of 40, run a clinical course of 15-20 years, and exhibit 
choreiform movements; rigidity is more characteristic of 
the rarer HD phenotype of children, which has a shorter 
course of 7-10 years. 
HD belongs to a growing number of inherited disorders 
in which the mutation is a trinucleotide repeat expansion 
(Bates and Lehrach, 1994; Willems, 1994). In HD, a CAG 
repeat at the 5' end of the coding region of IT15 expands 
from the normal 6-34 repeats to 38 or more repeats (The 
Huntington's Disease Collaborative Research Group, 
1993). in adult onset HD, the CAG repeat number is gener- 
ally in the range of 40-50; in juvenile onset HD, however, 
the repeat number is larger, sometimes exceeding 100. 
As with other CAG repeat disorders, triplet repeat expan- 
sion in HD has been inversely correlated with age of onset 
and rate of progression (Andrew et al., 1993; Duyao et al., 
1993; Snell et al., 1993; Stine et al., 1993). Studies have 
reported an invariable CAG repeat lengths in the brain 
and other organ tissues and between different brain re- 
gions within the same individual (MacDonald et al., 1993; 
Zuhlke et al., 1993). One group, however, has identified 
somatic heterogeneity in the CAG repeat length in the 
HD brain, with the greatest variation occurring in affected 
brain regions (cortex and striatum) of juvenile cases (Tele- 
nius et al., 1994). A widespread heterogeneity of the CAG 
repeat in brain has been described recently for other triplet 
repeat disorders (Chong et al., 1995; Ueno et al., 1995), 
but no correlation to selective brain pathology has been 
found. 
Immunocytochemical nd biochemical evidence shows 
a widespread distribution of huntingtin, the protein en- 
coded by IT15, and a localization in neuronal cell bodies, 
fibers, and nerve endings in the normal human brain (DiFi- 
gila et al., 1995; Sharp et al., 1995; Trottier et al., 1995). 
The consequences of the CAG expansion on huntingtin 
expression in the HD brain, however, are not clear. Despite 
the demonstration of both a normal and an expanded pro- 
tein in HD lymphoblasts (Trottier et al., 1995), a mutant 
protein predicted by the CAG expansion has not been 
clearly detected in the brain, raising questions about its 
existence or stability. HD heterozygotes express the mRNA 
for the normal and HD alleles in brain (Stine et al., 1995). 
This indicates that the potential for protein expression ex- 
ists. Clearly central to understanding the pathogenesis of 
HD are whether the expanded HD allele leads to an altered 
protein product in the brain, and whether such a protein 
distributes preferentially in affected brain regions. More- 
over, since a greater expansion of the CAG repeat is asso- 
ciated with a more severe form (early onset) of the illness, 
it is important o compare the pattern of huntingtin protein 
expression in children versus adults with HD. Finally, the 
influence of somatic heterogeneity in CAG repeat length 
on huntingtin protein expression needs to be explored for 
its potential role in selective brain pathology. 
The goal of this study, therefore, was to determine 
whether a mutant protein product is expressed in the HD 
brain and whether its regional distribution or biochemical 
features can be correlated with genetic, clinical, and neu- 
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ropathological features of the disease. Our findings show 
that, in HD heterozygotes, CAG expansion leads to the 
widespread expression of an altered protein product of 
increased size throughout the brain. The difference in mo- 
bility of mutant huntingtin relative to the wild-type protein 
correlates with CAG repeat expansion. Furthermore, the 
mutant protein migrates more broadly than the wild-type 
protein and in most juvenile cases consists of a complex 
of bands suggestive of somatic heterogenity in the CAG 
repeat expansion. The findings support a gain of function 
as the genetic basis for the disease and strengthen the 
idea that the pathogenesis of HD is due to the selective 
vulnerabiltyof some neurons to the presence of the mutant 
protein and its aberrant actions. 
Results 
Detection of Mutant Huntingtin in HD-Affected 
Cases: Relationship to CAG Repeat Length 
To determine whether an altered form of huntingtin was 
expressed in the HD brain and how expression was af- 
fected by the extent of CAG expansion, we examined hun- 
tingtin in synaptosomal preparations of frontal cortex from 
22 HD brains (11 adult onset and 11 juvenile onset) and 
8 control brains (unaffected; Table 1). Proteins were sepa- 
rated by SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) and transferred to nitrocellulose membranes, 
which were probed with antisera directed against the 
N-terminus (amino acids 1-17; Ab 1) of huntingtin and an 
internal protein sequence (amino acids 585-745; Ab 585) 
downstream from the polyglutamine region. As previously 
reported (DiFiglia et al., 1995), immunoreactive huntingtin 
is detected with these antisera at approximately its pre- 
dicted MW (estimated size is 348 kDa) in synaptosomes 
from human control cortex. The native protein is also pres- 
ent in heterozygous HD brain of adult and juvenile onset 
cases (Figure 1). A mutant protein of comparable intensity 
to the wild type was also seen in the HD brains. The mutant 
species was distinguishable as a separate protein band 
in all HD cases except patient A11, who had the smallest 
expanded allele tested (40 CAG repeats) and a difference 
from the normal allele of only 15 CAGs. In this case, the 
mutant protein appeared as a fuzzy upward extension of 
the wild-type band. The mutant protein was also seen in 
an HD patient who was presymptomatic at the time of 
death (Figure 1, case A4) and showed evidence of grade 
1 pathology (minimal neuronal oss in the striatum) on post- 
mortem examination. Adult onset cases with identical esti- 
mates of CAG repeat expansion showed different de cjrees 
of separation of the normal and mutant proteins on the 
immunoblot. The space between the two bands was invari- 
able when immunoblots were repeated, suggesting that 
the relationship in electrophoretic mobility between the 
normal and mutant species was an inherent property of 
the proteins. 
The slower migratory mutant band occurred at various 
positions above the wild-type protein up to an apparent 
MW range of 450 kDa for upper alleles with the largest 
number of CAG repeats. Thus, the increase in apparent 
Table 1. Cases Used to Examine Huntingtin i  Brain 
Diagnosis/ Number of
Case Sex Age Grade CAG Repeats 
C1 M 55 Control 17/17 
C2 F 93 Control 17•22 
C3 M 66 Control NA 
C4 M 78 Control 22/24 
C5 M 77 Cont rol 17/17 
C6 M 81 Control 15/17 
C7 F 35 Control 17/18 
C8 M 68 Control 9/17 
C9 M 63 Control NA 
A1 M 35 HD4 22/44 
A2 F 62 HD3 16•43 
A3 M 57 HD2 17143 
A4 F 32 H D 1 17142 
A5 M 63 H D3 19144 
A6 F 84 HD3 15/40 
A7 M 44 H D3 19/44 
A8 F 61 HD3 17/41 
A9 M 58 H D3 17/44 
A10 M 63 HD3 23•43 
A11 F 40 HD2 25•40 
A 12 F 66 H D3 27•42 
J 1 F 6 H D3 10/150 °
J2 F 16 HD 20•67 
J3 F 39 H D4 19•65 
J 4 F 17 H D 17•72 
J5 F 28 HD3 15/69 
J6 F 12 HD4 17/105 
J7 M 17 HD 17/91 
J8 M 9 HD 27•90 
J9 M 6 HD 181125" 
J 10 M 19 H D 20•68 
J l l  F 16 HD3 17/83 
Control (C1-C9), adult (A1-#.11 ),and juvenile (J 1.-J11) HD cases ex- 
amined in this study. Age indicated is at the time of death. The patho- 
logical grade is provided where it was available and is based on the 
grading system of Vonsattel et al. (1985). A grade of 1 means that 
there is minimal cell loss in the striatum, and a grade of 4 indicates 
severe atrophy, neuronal loss in the striatum, and involvement ofother 
brain regions. CAG repeats for the normal and expanded alleles are 
given for the cortex with a few exceptions in the juvenile cases, where 
only cerebellar tissue was available. NA, not available. 
a Based on estimate from Southern blot. 
size of mutant huntingtin exceeded the actual increase in 
MW of 2-10 kDa predicted by the expanded polyglutamine 
region. Computer-assisted image analysis showed that for 
all HD cases the distance of the peak separation between 
mutant and wild-type huntingtin protein was highly corre- 
lated (r = 0.84, p < .0001 ; Pearson correlation coefficient) 
with the difference in the number of CAG repeats between 
the normal and mutant alleles (Figure 2). The adult onset 
HD group alone also exhibited a significant positive corre- 
lation (r = 0.63, p < .03). The results were similar for the 
two anti-huntingtin antisera (Ab 1 and Ab 585) used in the 
analysis. 
Widespread Expression of Mutant Huntingtin 
in the Brain 
One possible explanation for the region-specific degener- 
ation in HD is that the mutant protein is expressed only 
in affected brain regions such as the striatum and cortex. 
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Figure 1. Immunoblots of Control and HD 
Brain Cortex Synaptosomes Probed with Ab 1 
Controls (C2, C3, and C8) and HD cases (A2, 
A3, A4, Al l ,  J5, and J6) are shown with the 
CAG repeat length for each pair of alleles indi- 
cated at the top. HD case A4 is from a patient 
who was presymptomatic at the time of death. 
All cases except for A4 are from the same im- 
munoblot. The mutant protein runs as a sepa- 
rate band in all HD cases except Al l ,  which 
had the smallest expanded allele xamined. 
Protein concentrations varied from 10 to 25 p.g 
per lane. Molecular weight standards in kilodal- 
tons are shown on the left. 
Therefore, we compared huntingtin expression in a variety 
of cortical and subcortical gray and white matter regions 
in a control case, an adult HD case, and a juvenile HD 
case (case J11). Detection of native huntingtin in the con- 
trol case (Figure 3A) showed a similar signal throughout all 
gray matter areas examined. Similarly, in the HD-affected 
brain (Figure 3B), mutant huntingtin was detected along 
with the wild-type protein in all areas of gray matter in both 
the juvenile (Figure 3B) and adult onset (data not shown) 
patients. In addition to its widespread expression in gray 
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Figure 2. Comparison of CAG Repeat Length and the Difference in 
Migration of Immunoreactive Huntingtin Protein Peaks in Cortex Syn- 
aptosomes 
CAG repeat length is plotted as the difference in size between the two 
alleles. The migration ofwild-type and mutant huntingtin is indicated 
as the distance in millimeters between protein bands as determined 
by computer-assisted image analysis. The difference in p ak separa- 
tion in the control cases is assumed to be zero since only one peak 
could be detected. For all cases, r ~ 0.89 with p < .0001; if control 
cases are not included, r = 0.84 with p < .0001. For adult HD only, 
r = 0.64, p < .03; for juvenile HD only, r = 0.59, not significant. 
matter, a relatively strong signal for huntingtin was de- 
tected in some regions of white matter, particularly the 
subcortical white matter, the centrum semi-ovale, and the 
corpus callosum in both the normal and HD brain. In gen- 
eral, forebrain regions produced stronger expression of 
mutant huntingtin than hindbrain areas in the HD brain. 
The HD cerebellum consistently exhibited a weaker sig- 
nal in both wild-type and mutant protein expression than 
the cortex in a series of adult and juvenile HD cases where 
the two regions were compared (Figures 4A and 5). Manip- 
ulation of protein concentration and the method of protein 
extraction (total extracts versus synaptosomes) did not 
account for the weaker signal in the cerebellum. Analysis 
of hematoxyl in- and eosin-stained sections of the cortex 
and cerebellum available for 3 of the cases (J5, J7, and 
J10) showed that the density of neurons in the cerebellum 
was comparable to that of controls and was mildly to mod- 
erately reduced in regions of the cortex of these cases 
(data not shown). 
Mutant Huntingtin Migrates as a Broad Band: 
Evidence for Somatic Mosaicism 
The mutant protein migrated more broadly than the wild 
type. To compare the relative expression of the two protein 
products in each HD case, the normal and mutant proteins 
were quantified by measuring the absolute breadth (width) 
and the relative amount (integrated area of the density 
plot) of each band. Immunoblots showed that the signal 
of mutant huntingtin was significantly broader in size 
(width, p < .001, t test, paired comparisons) and greater 
in overall integrated area (integrated area, p < .001, t test, 
paired comparisons) than the corresponding wild-type 
huntingtin (Table 2). These differences were found with 
both antisera. The patterns of change in mutant and wild- 
type huntingtin were more pronounced in juvenile than in 
adult cases; this finding was especial ly robust with use of 
the N-terminal antisera (Ab 1 ; Table 2). 
The broad band characteristic of mutant huntingtin was 
most striking in cortex and least apparent in the cerebel- 
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Figure 3. Regional Distribution of Huntingtin 
in Control and HD Brain 
(A) Immunoblot of P2 fractions (20 p.g/lane) 
from 8 regions of control brain (case C9) probed 
with Ab 1. The native protein (arrow) is detected 
in all regions of gray and white matter sampled. 
(B) Immunoblots of P2 fractions (20 I~g/lane) 
from a juvenile HD (case J l l )  brain show the 
presence of both the normal (arrows) and mu- 
tant (arrowheads) proteins in all regions, in- 
cluding both gray and white matter. The mutant 
protein appears as intense as the coexpressed 
normal protein but is more broadly distributed 
in the cortex, caudate, putamen, substantia ni- 
gra, and white matter regions. The panel is 
compiled from three immunoblots processed at 
the same time with similar exposures. Protein 
extractions, separations, and immunoblotting 
conditions were the same in the control and 
HD cases. 
(C) Less exposed images of some of the same 
regions shown in (B). Note the presence of mul- 
tiple bands in both more affected (caudate and 
putamen) and less affected (striate cortex and 
pons) areas. 
CBL, cerebellum; Cd, caudate; Cing, cingulate 
cortex; CSO, centrum semi-ovale; FC, frontal cortex; Forb, frontal orbital; GPI, lateral globus pallidus; GPm, medial globus pallidus; Inf P r, inferior 
parietal cortex; Put, putamen; SCC, splenium of the corpus callosum; SNC, substantia nigra, pars compacta; SNR, substantia nigra, pars reticulata; 
STCTX, striate cortex; TCTX, temporal cortex; WM, subcortical white matter. 
lum, particularly in the juvenile cases (Figures 4A and 5). 
A quantitative comparison of the cortex and cerebellum 
in a group of adult and juvenile cases confirmed that there 
was a larger ratio of the integrated area of the mutant 
to wild-type bands (area ratio) in the cortex than in the 
cerebellum in both the adult (p < .001, t test, paired com- 
parisons) and juvenile (p < .001) cases (see Figure 4C). 
Reducing the amount of protein analyzed in the cortical 
sample from 20 to 2 p_g did not alter the broadness of the 
mutant band (data not shown), indicating that the larger 
size was not dependent on the amount of protein loaded. 
In the cortex of 6 of the 11 juvenile cases examined, 
we noticed that, at brief film exposures of the chemilumi- 
nescent reaction, mutant protein was resolved as two or 
three distinct bands. This heterogeneity in mutant hunting- 
tin was seen in cases J11 (see Figure 3C), J5 (see Figure 
4B), J2 (see Figure 5), J8, and J10. In contrast to the cortex, 
the cerebellum exhibited multiple mutant bands in only 2 
of the 11 juvenile HD patients, cases J1 (see Figure 4B) 
and J10. Of the 16 regions examined in case J l l ,  two 
distinct mutant bands were discernible in most brain ar- 
eas, including all areas of the cortex, the subcortical white 
matter, the caudate, putamen, substantia nigra, and pons 
but not the cerebellum (see Figure 3C). Thus, both affected 
(cortex and striatum) and unaffected (pons and cerebel- 
lum) brain regions in HD may exhibit heterogeneity in mu- 
tant huntingtin expression; the cerebellum is a region where 
the occurrence of multiple mutant species is very low. 
To determine whether somatic mosaicism in CAG re- 
peat length of the expanded HD allele (Telenius et al., 
1994) accounted for the heterogeneity in mutant hunting- 
tin, we selected 2 juvenile and 2 adult onset cases in which 
the mutant protein appeared broader in the cortex than 
in the cerebellum. The broad mutant protein in 1 of the 
juvenile cases (J5) showed three distinct bands, while that 
in the other case (J6) did not (see Figure 4A). Consistent 
with previous findings (Telenius et al., 1994), the cortex in 
both juvenile cases (Figure 6, case J5) exhibited a greater 
spread in the polymerase chain reaction (PCR) smear 
(25%-50% increased span) and a displacement upward 
of the estimated major allele band compared with the cere- 
bellum (69 versus 62 in case J5 [see Figure 5]; 105 versus 
95 in case J6). In the 2 adult onset cases, the range of 
bands was small and similar in both regions, with the major 
band being identical in the 2 brain regions (42 versus 42 
in case A4; 43 versus 43 in case A2; data not shown). 
Thus, it appears, at least in the juvenile cases, that the 
increased size and heterogeneity (multiple bands) in mu- 
tant huntingtin can be explained by the presence at the 
DNA level of greater heterogeneity and larger repeat 
lengths of the HD allele in the cortex than in the cerebel- 
lum. The absence of a similar relationship in the adult 
cases between genomic DNA heterogeneity and mutant 
huntingtin expression may be due to limitations in the sen- 
sitivity of the PCR assay. Somatic mosaicism of CAG re- 
peat length in adult onset HD brain is less obvious than 
in juvenile cases (Telenius et al., 1994). Also, other tissue- 
specific factors involved with posttranslational processing 
may contribute to the broader spread of mutant huntingtin 
in the brain. 
Assessment of Other Factors Possibly Contributing 
to the Broad Spread of Mutant Protein 
To assess whether N-glycosylation or incomplete denatur- 
ation of mutant huntingtin contributed to its broader size, 
synaptosome extracts from the cortex and cerebellum of 
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Figure 4. Comparison of Huntingtin i  Cortex and Cerebellum of the 
HD Brain 
(A) Immunoblot of 1 adult onset case (case A2) and 3 juvenile onset 
cases (J1, J5, and J6). J1 is taken from a different gel than the other 
cases. The CAG repeat length is shown at the top. A total of 20 p.g 
of synaptosomal protein was loaded in each lane. 
(B) Higher magnification of cortex from case J5 (left) and of cerebellum 
from case J1 (right) shows the presence of multiple bands (arrows) in 
mutant huntingtin. Adjacent optical density plots for each case show 
the resolution of the wild-type and mutant bands. Multiple mutant 
bands were much more frequent in the cortex (6 of 11 cases) than in 
the cerebellum (2 of 11 cases) of the juvenile HD brain. 
(C) Comparison of the mean area/intensity ratio of mutant versus wild- 
type huntingtin in the cortex and cerebellum of 6 adult and 7 juvenile 
onset cases. Vertical bars indicate SEM. In both the adult and juvenile 
cases, the area ratio is significantly different between the cortex and 
the cerebellum. Asterisk denotes p < .001 (t est on paired com- 
parisons). 
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Figure 5. Comparison of Immunoreactive Huntingtin in the Cortex and 
Cerebellum of Juvenile Case J2 
A total of 20 I~g of synaptosomal extracts was loaded in each lane. 
The cortex produces a stronger signal on the immunoblot han the 
cerebellum for both wild-type and mutant protein. The signal for the 
160 neurofilament protein reprobed on the same blot shown below 
(arrow) is about the same for each region. Molecular weight sizes 
(kilodaltons) are shown on the left. 
the same 2 juveni le  onset  cases (J5 and J6) were treated 
with N-g lycos idase F or 4 M urea prior to SDS-PAGE and 
immunoblot .  No change in the broad band character ist ic 
of mutant  hunt ingt in  was ev ident  with either t reatment  con- 
dit ion (Figure 7). 
Ubiquit in is an 8.5 kDa protein that con jugates  to pro- 
teins undergo ing  proteolyt ic degradat ion (Carlson et al., 
1987). S ince ubiqui t inated proteins react as a "smear"  on 
immunoblots  (Mor i sh ima-Kawash ima et al., 1993) and ubi- 
quit in-posit ive dystrophic  neur i tes are found in the HD cor- 
tex (Cammarata  et al., 1993), we invest igated whether  the 
broad mutant  hunt ingt in band seen in the juveni le  HD cor- 
Table 2. Analysis with Ab 1 of Huntingtin Protein Products in the Control and HD Brain 
Width 
Peak (mean _+ SEM) 
Separation 
(mm) Wild Type Mutant 
Area 
(mean ± SEM) 
Wild Type Mutant 
Controls 9 0.0 1.1 _+ .05 - 
Adult onset 12 0.68 ± .06 0.95 --_ .05 1.23 ± .07 c 
Juvenile onset 11 2.43 ± .23 1.0 ± .04 2.28 _+ .20 ~ 
All HD 23 1.47 ± .23 0.98 + .03 1.80 ± .16 d 
0.21 - .03  
0.16 ± .03 0.24 ± .05" 
0.21 - .05 0.66 ± .15 b 
0.19 - .03 0.43 ± .09 ¢ 
Mutant compared with wild type, p < .05. 
b p < .01. 
c p < .005. 
p < .0001. 
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Figure 6. Comparison of CAG Repeat Expansion of the HD Allele in 
the Cortex and Cerebellum of Case J5 Using a PCR Assay 
The cortex yields a product with a greater siz  of the major band 
(estimated 69 repeats) and a greater spread ofthe PCR smear than 
the cerebellum (major band estimated 62 repeats), providing support 
for somatic variation. The PCR product from the other allele (shown 
below) was the same size for both brain regions. Similar results were 
obtained for case J6. A DNA sequencing ladder was performed with 
the assay and used to estimate the number of CAG repeats (indicated 
on the right). 
tex was due to ubiquitin conjugation. No evidence for ubi- 
quitin immunoreactivity was identified in the region of mu- 
tant huntingtin on immunoblots of synaptosomal extracts 
from HD cases J5 and J6 when probed directly with a 
203- 
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Figure 7. Analysis of the Effect of Denaturation with 4 M Urea and 
Deglycosylation on the Expression of Mutant Huntingtin in Juvenile 
Onset Case J5 
From left to right: pretreatment with 4 M urea prior to SDS-PAGE 
(+); no urea control (-); treatment with N-glycosidase-F overnight (+); 
incubation buffer alone (-). The same results were obtained for case 
J6. Molecular weight markers are shown on the left. 
polyclonal anti-ubiquitin antibody. Similarly, when protein 
extracts of these same cases were incubated with anti- 
ubiquitin antisera and the immunoprecipitated proteins 
were immunoblotted with Ab 1, immunoreactive huntingtin 
was not observed. These results suggest that ubiquitin 
conjugates do not explain the broad band or complex of 
bands seen on immunoblots of the juvenile HD cortex. 
Discussion 
This study has shown that a mutant form of huntingtin is 
detectable throughout he HD brain and that its increased 
size in relation to the wild-type protein is highly correlated 
with CAG repeat expansion. These findings, together with 
previous evidence for the association of large repeat 
expansions with early onset and increased clinical severity 
in HD (Andrew et al., 1993; Duyao et al., 1993; Stine et 
al., 1993), suggest that the progressive increase in the 
size of mutant huntingtin is associated with its abnormal 
function. Mutant huntingtin is not preferentially expressed 
in regions of known pathology, and thus other factors in 
conjunction with the presence of the altered protein must 
contribute to the vulnerability of affected neurons. The 
detection of mutant huntingtin in synaptosomes indicates 
that the altered protein is expressed and transported to 
axon endings at levels similar to those of wild-type protein 
throughout he brain. The wild-type and mutant huntingtin 
also exist in the white matter, an observation that has not 
been previously reported in the normal or HD brain. This 
localization may include axons and nonneuronal cells and 
could be important for understanding why there is marked 
atrophy of the cortical white matter as well as the gray 
matter in HD brain (De La Monte et al., 1988). Why hunting- 
tin expression in the cerebellum is harder to detect in the 
HD brain than in the normal brain is unclear. Our ability 
to see a robust signal for both mutant and wild-type hun- 
tingtin in HD brain compared with the detection of only 
the normal protein by Trottier et al. (1995) may be related 
to our use of a low bis-acrylamide for SDS-PAGE. During 
the review of this paper, another group (Ide at al., 1995) 
reported that the use of lower concentrations of bis- 
acrylamide significantly improved the detection of an ab- 
normal huntingtin product in HD lympoblasts and cerebral 
cortex. The expression in brain of a mutant ataxin protein 
in spinocerebellar ataxia type 1 (Servadio et al., 1995) 
has also been described. This finding, together with the 
observations in HD, suggests that the expression in brain 
of altered proteins from disease genes encoding ex- 
panded CAG repeats may be a shared feature of triplet 
repeat disorders. 
Our findings support the view that HD pathogenesis is 
due to a gain of function in which an aberrant action 
emerges from the presence of an altered protein in the 
brain. The mutant protein by our estimates is expressed 
comparably to the normal protein and is transported to 
axon endings, where it conceivably has access to the 
same intracellular targets a the normal huntingtin. In this 
context, HD may be viewed as a condition where the mu- 
tant protein competes with the normal species for intracel- 
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lular targets. It is likely that the mutant huntingtin pos- 
sesses at least some normal function. Recent evidence 
in mice with disrupted IT15 revealed that the embryo dies 
by day 8.5 (Nasir et al., 1995; Duyao et al., 1995). If the 
mutant HD were completely dysfunctional, homozygous 
HD would be incompatible with life. This is not the case; 
HD homozygotes have a phenotype often indistinguish- 
able from the heterozygous individual (Wexler et al., 1987). 
Thus, it is likely that the mutant protein shares many of the 
normal function(s) of the wild-type protein and additionally 
has encumbered features that lead to aberrant interac- 
tions. 
Our findings show that the slower mobility (increased 
size) of mutant huntingtin can be largely attributed to the 
presence of additional glutamines. Polyglutamine se- 
quences are recognized to be potential sites of protein- 
protein interactions, and the aberrant expansion of these 
regions, particularly as occurs in juvenile HD, may be con- 
ducive to the formation of deleterious protein complexes 
(Perutz et al., 1994). The increased size of mutant hunting- 
tin in brain appears to exceed the MW predicted by the 
addition of extra glutamines, suggesting that the expan- 
sion causes a conformational change in the mutant pro- 
tein. Similar conclusions are suggested from the study of 
HD lymphoblasts and the in vitro expression of huntingtin 
with variable CAG repeat lengths in COS cells (Trottier et 
al., 1995). Altered mobility suggestive of a conformational 
change has also been described for the mutant gene prod- 
uct in dentatorubral-pallidoluysian trophy brain (Yazawa 
et al., 1995). In our study, the difference in sensitivity of 
the two antisera to mutant huntingtin in the juvenile cases 
may have resulted from changes in epitope presentation 
brought about by structural changes in the mutant protein, 
The broader spread of the mutant protein relative to 
the wild-type protein can be largely attributed to somatic 
heterogeneity in CAG repeat length, as first reported with 
genomic PCR analysis in HD (Telenius et al., 1994), con- 
firmed in this study, and also recently described for other 
triplet repeat disorders (Chong et al., 1995; Ueno et al., 
1995). The strongest support for somatic heterogeneity at 
the protein level was shown in the juvenile cases in which, 
under appropriate conditions, distinct bands could be re- 
solved in the mutant protein. This finding provides clear 
evidence that somatic heterogeneity results in the transla- 
tion of multiple mutant protein products. We predict that 
the characteristic of variable protein expression seen for 
mutant huntingtin in HD also exists for the expanded pro- 
teins encoded by other CAG repeat disease genes. Our 
findings that somatic mosaicism at the protein level is 
widespread throughout the brain, is evident in juvenile 
cases, and is least apparent in the cerebellum parallel 
previous observations at the genomic DNA level (Telenius 
et al., 1994). We found no support for a causal relationship 
between somatic variability and HD pathology, since het- 
erogeneity in mutant protein expression occurred in both 
affected and nonaffected brain areas. However, the more 
frequent and striking occurrence of mutant protein hetero- 
geneity in forebrain areas that are more degenerated in 
HD may be significant in contributing to the severity and 
phenotypic expression of the disease. The cellular origin 
of the multiple mutant huntingtin protein products is un- 
known. Proliferating nonneu ronal cells are a likely source, 
particularly in affected areas where neurons are the most 
depleted. Further study is needed to determine the cellular 
origin of the variable mutant proteins and their possible 
regional contribution to pathological and functional changes 
in HD-affected individuals. 
Experimental Procedures 
Tissue Procurement 
Brain tissue was obtained from the Brain Tissue Resource Center 
(Belmont, MA), the University of Massachusetts, Department of Neuro- 
pathology, and the Massachusetts General Hospital Neuropharmacol- 
ogy Laboratory Brain Bank. All tissue was quickly frozen and stored 
at -70°C until further analysis. The time between death and brain 
dissection was variable but was always between 4 and 48 hr. The 
dissections of neocortex and cerebellar cortex were performed so as 
to exclude the underlying white matter as much as possible. Control 
tissue from donors without HD was handled identically. Most of the 
adult onset HD cases were evaluated for neuropathological status and 
assigned a grade according to the criteria of Vonsattel et al. (1985). 
The majority of adult onset cases were grade 3. 
Synaptosome Preparation 
The protocol of Koenig (1974) was used. The brain tissue was slowly 
thawed on ice in homogenization buffer containing 0.32 M sucrose with 
0.1 M phenylmethylsulfonyl fluoride (PMSF) and 2 mg/ml pepstatin A. 
After homogenization and centrifugation, the suspension was layered 
on a discontinuous ucrose gradient (layers 0.32 M, 0.8 M, 1.0 M, 1.2 
M, and 1.4 M). The gradient was centrifuged at 65,000 × g for 2 hr. 
Synaptosomal fractions at the interfaces of 1.0 to 1.2 M were collected 
and stored at 70°C. P2 fractions were prepared as described by 
DiFiglia et al. (1995). 
Protein Separation and Western Blot Analysis 
Protein fractions (fraction C; 10-20 pg per lane) were submitted to 
SDS-PAGE using a 10% acrylamide gel containing 0.05% bis- 
acrylamide. The 200 kDa standard was allowed to run to the middle 
of the gel for all runs. Following transfer to nitrocellulose, blots were 
probed with Ab 1 (0.5 p.g/ml), which recognizes N-terminal amino acids 
1-17 of huntingtin, or AD 585 (1:4000), which was raised to residues 
at positions 585-745 of huntingtin in a region -540 residues C-ter- 
minal to the polyglutamine domain. Most cases were evaluated with 
both antisera and probed on different blots at least twice. Immunoreac- 
tivity was detected using enhanced chemiluminescence (ECL, Amers- 
ham). Film autoradiograms were exposed from 2 s to 4 hr. 
CAG Repeat Determination 
CAG repeat length was analyzed by PCR and Southern blotting of 
genomic DNA extracted from brain tissue. PCR assays were per- 
formed using a procedure and primers described previously (Goldberg 
et al., 1993) and resolved on denaturing polyacrylamide (sequencing) 
gels. In a few cases where amplification by PCR was not obtained, 
Southern blotting was used to estimate the length of CAG repeats. 
Pstl digests of genomic DNA were resolved by agarose gel electropho- 
resis and transferred to nitrocellulose filters. The filters were probed 
with a 366 bp genomic fragmenL which was prepared by PCR using 
primers labeled with 32p by random-primed synthesis. 
Deglycosylation Assay 
Synaptosome xtracts (20 ~g) from the cortex and cerebellum of 2 
juvenile onset cases were treated in 10% SDS, heated to 100°C for 
2 min, and treated with incubation buffer (1 M sodium phosphate [pH 
7.4], 30 mM EDTA, 0.5% Nonidet P40, 0.1% 2-mercapto-ethanol, 0.5 
mM PMSF, 1 ~g/ml pepstatin A) alone or in the presence of N-gly- 
cosidase F (PNGase F, Boehringer Mannheim Biochemica) at 37°C 
overnight. Invertase was used as the control glycosylated protein. 
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Ubiquitination Protocol 
Synaptosomal extracts (10 p.g) from HD brains were treated with anti- 
ubiquitin antibody (mouse monoclonal, 1 I~1, DAKO) in NET gel buffer 
(50 mM Tris [pH 7.5], 0.1% Nonidet P-40, 0.25% gelatin, 0.15 M NaCI, 
0.02% sodium azide, 1 mM EDTA). The mixture (total volume of 100 
I~1) was incubated overnight at 4°C on a rocker. Protein A Sepharose 
CL-4B (Sigma) was added, and the mixture was incubated for 1 hr at 
4°C and then centrifuged at 10,000 x g for 1 min. After three washes 
in NET buffer, the Sepharose-protein complex was washed in Tris 
(pH 6.8) and placed into a new tube. SDS loading buffer and the mixture 
were boiled for 1.5 min prior to loading on a low bis, 10% SDS-poly- 
acrylamide gel. Proteins were transferred to nitrocellulose, and West- 
ern blot analysis was performed using Ab 1. 
Image Analysis and Statistical Methods 
Immunoblots were quantified using computer-assisted image analysis 
(M1, Imaging Research Inc., St. Catherines, Ontario). A standard den- 
sity gradient and size calibration scale were set prior to measurement 
of the autoradiograms. After the images were scanned, a density distri- 
bution plot of the protein bands present in each lane was generated 
and displayed on the computer monitor. The following measurements 
were defined from the density plot: the location of maximal density of 
each protein band (peak location); the width (broadness) of each band; 
and the integrated area of each distribution (area). "Peak separation" 
was defined as the distance in millimeters between the peak location 
of two bands present in the same lane. When more than two bands 
were resolved in a lane, the two lowest bands were used to calculate 
peak separation. The ratio of the upper (mutant) band to the lower 
(wild-type) band was calculated using the width (width ratio) and area 
(area ratio) measurements obtained as described above. Statistical 
analysis included ANOVA, t tests for paired comparisons, and Pearson 
product-moment correlations. 
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